GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of UNCY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Unicycive Therapeutics, Inc.
(Updated on Apr 19, 2024)

Sell candidate since Apr 12, 2024 Loss -12.30% PDF

The Unicycive Therapeutics, Inc. stock price fell by -1.83% on the last day (Friday, 19th Apr 2024) from $1.09 to $1.07. During the last trading day the stock fluctuated 7.62% from a day low at $1.05 to a day high of $1.13. The price has fallen in 9 of the last 10 days and is down by -24.65% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -667 thousand shares and in total, 226 thousand shares were bought and sold for approximately $242.15 thousand.

Given the current short-term trend, the stock is expected to rise 19.39% during the next 3 months and, with a 90% probability hold a price between $1.28 and $2.38 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

UNCY Signals & Forecast

There are few to no technical positive signals at the moment. The Unicycive Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.15 and $1.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 23, 2024, and so far it has fallen -40.22%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Unicycive Therapeutics, Inc. stock

Unicycive Therapeutics, Inc. finds support from accumulated volume at $1.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0800 between high and low, or 7.62%. For the last week the stock has had daily average volatility of 9.61%.

Unicycive Therapeutics, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UNCY) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Unicycive Therapeutics, Inc. to open at $1.08, and during the day (based on 14 day Average True Range), to move between $0.96 and $1.18, which gives a possible trading interval of +/-$0.114 (+/-10.64%) up or down from last closing price. If Unicycive Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 21.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.09 (1.87%) than the support at $1.05 (1.87%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Unicycive Therapeutics, Inc. stock A Buy?

The Unicycive Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Unicycive Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.789 Sell Candidate Unchanged

Predicted Opening Price for Unicycive Therapeutics, Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$1.08 ( 1.25%) $1.07

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for UNCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.16 8.72 %
R2 1.13 5.87 %
R1 1.11 4.10 %
Current price: 1.07
Support S1 1.05 -1.61 %
S2 1.03 -3.37 %
S3 1.00 -6.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.14 6.54 %
R2 1.12 4.67 %
R1 1.09 1.87 %
Current price 1.07
Support S1 1.05 -1.87%
S2 1.00 -6.54%
S3 0.98 -8.13%

FAQ

What is the symbol for Unicycive Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Unicycive Therapeutics, Inc. is UNCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Unicycive Therapeutics, Inc. Stock?
The Unicycive Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Unicycive Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Unicycive Therapeutics, Inc. Stock?
Unicycive Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Unicycive Therapeutics, Inc. Stock.

What's the current price of Unicycive Therapeutics, Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Unicycive Therapeutics, Inc. (UNCY) share was $1.07.

What is the 52-week high and low for Unicycive Therapeutics, Inc. Stock?
The 52-week high for Unicycive Therapeutics, Inc. Stock is $1.82 and the 52-week low is $0.470.

What is the market capitalization of Unicycive Therapeutics, Inc. Stock?
As of the 2024-04-19, the market capitalization of Unicycive Therapeutics, Inc. is 37.189M.

When is the next earnings date for Unicycive Therapeutics, Inc.?
The upcoming earnings date for Unicycive Therapeutics, Inc. is May 21, 2024.
Click to get the best stock tips daily for free!

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics. Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.... UNCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT